ItalyOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Obstetrics & Reproductive Medicine
Rank in SubField 1: 1,706 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38,281 | 41,318 |
| Total Cites | 19,930 | 22,349 |
| H-index | 69 | 73 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 57 | 63 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 4,348 | 4,653 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 5,379 | 5,802 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14,225 | 15,245 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.47 |
| Self-Citation Percentage |
10.82%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Obstetrics & Reproductive Medicine
Rank in SubField 1: 1,821 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40,916 | 42,372 |
| Total Cites | 16,864 | 18,935 |
| H-index | 65 | 68 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 54 | 60 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 3,681 | 3,934 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 4,564 | 4,929 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12,257 | 13,176 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.44 |
| Self-Citation Percentage |
10.94%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Obstetrics & Reproductive Medicine
Rank in SubField 1: 1,860 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 41,666 | 43,540 |
| Total Cites | 15,420 | 17,336 |
| H-index | 62 | 65 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 54 | 60 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 3,411 | 3,651 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 4,228 | 4,576 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,325 | 12,194 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.42 |
| Self-Citation Percentage |
11.05%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Obstetrics & Reproductive Medicine
Rank in SubField 1: 2,368 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53,049 | 56,816 |
| Total Cites | 11,932 | 13,292 |
| H-index | 57 | 60 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 39 | 45 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 2,450 | 2,576 |
| Number of Single+First+Last Authored Papers | 71 | 71 |
| Total Cites to Single+First+Last Authored Papers | 3,107 | 3,325 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9,161 | 9,894 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.34 |
| Self-Citation Percentage |
10.23%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.